Brussels – AFP
On Sunday, the European Commission announced that it had reached an agreement with “Biontech” and “Pfizer” to facilitate vaccination campaigns for member countries to add an additional 20 million doses of vaccine against the Covit-19 vaccine in the first half of 2022. .
The commission in Brussels noted that it had “implemented the first option to order over 200 million doses under a third contract concluded with Pfizer / Beyonc”. “If these vaccines are available, this request will include effective vaccines against the clumsy Omicron,” he said, noting that deliveries are scheduled for the second quarter of 2022.
He added in a statement: “In the first quarter of next year, Pfizer / Biontech will provide an additional 20 million vaccines (five million in January, five million in February and ten million in March). These doses were added to the 195 million doses previously agreed with Pfizer / Biontech, bringing the total number of deliveries in the first quarter to 215 million.
Agreed with Moderna Group to provide additional volumes in the first quarter of 2022.
“The administration of vaccine extension and booster doses for all is very important and urgent,” EU leaders said during a summit on Thursday.
“In light of the rapid increase in the number of infections expected with the Omigran mutation, this issue is more urgent than ever,” the commission said.
The European Commission had previously said in mid-January that Omicron could become the most widespread mutant in European countries; 67% of the total population was vaccinated.